AU623779B2 - New porus pharmaceutical form and its preparation - Google Patents

New porus pharmaceutical form and its preparation

Info

Publication number
AU623779B2
AU623779B2 AU55828/90A AU5582890A AU623779B2 AU 623779 B2 AU623779 B2 AU 623779B2 AU 55828/90 A AU55828/90 A AU 55828/90A AU 5582890 A AU5582890 A AU 5582890A AU 623779 B2 AU623779 B2 AU 623779B2
Authority
AU
Australia
Prior art keywords
new
pct
porus
preparation
pharmaceutical form
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU55828/90A
Other languages
English (en)
Other versions
AU5582890A (en
Inventor
Frederic Courteille
Magali Vanhoeve
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rhone Poulenc Sante SA
Original Assignee
Rhone Poulenc Sante SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Sante SA filed Critical Rhone Poulenc Sante SA
Publication of AU5582890A publication Critical patent/AU5582890A/en
Application granted granted Critical
Publication of AU623779B2 publication Critical patent/AU623779B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40—Cyclodextrins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nanotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • Materials For Medical Uses (AREA)
  • Filtering Materials (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU55828/90A 1989-05-24 1990-05-22 New porus pharmaceutical form and its preparation Ceased AU623779B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8906781A FR2647343B1 (fr) 1989-05-24 1989-05-24 Nouvelle forme pharmaceutique poreuse et sa preparation
FR8906781 1989-05-24

Publications (2)

Publication Number Publication Date
AU5582890A AU5582890A (en) 1991-01-10
AU623779B2 true AU623779B2 (en) 1992-05-21

Family

ID=9381955

Family Applications (2)

Application Number Title Priority Date Filing Date
AU55828/90A Ceased AU623779B2 (en) 1989-05-24 1990-05-22 New porus pharmaceutical form and its preparation
AU57433/90A Ceased AU631888B2 (en) 1989-05-24 1990-05-22 New imipramine-based compositions

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU57433/90A Ceased AU631888B2 (en) 1989-05-24 1990-05-22 New imipramine-based compositions

Country Status (24)

Country Link
US (1) US5244881A (forum.php)
EP (2) EP0399903B1 (forum.php)
JP (1) JP2948271B2 (forum.php)
KR (1) KR0163423B1 (forum.php)
AT (2) ATE83663T1 (forum.php)
AU (2) AU623779B2 (forum.php)
CA (2) CA2017360A1 (forum.php)
DD (1) DD297915A5 (forum.php)
DE (2) DE69005359T2 (forum.php)
DK (2) DK0399903T3 (forum.php)
ES (2) ES2054289T3 (forum.php)
FI (1) FI103712B (forum.php)
FR (1) FR2647343B1 (forum.php)
GR (1) GR3006655T3 (forum.php)
IE (2) IE64370B1 (forum.php)
IL (2) IL94460A0 (forum.php)
NO (1) NO180517C (forum.php)
NZ (2) NZ233766A (forum.php)
PL (1) PL285327A1 (forum.php)
PT (2) PT94138B (forum.php)
TW (1) TW257672B (forum.php)
WO (1) WO1990014089A1 (forum.php)
YU (1) YU100790A (forum.php)
ZA (2) ZA903895B (forum.php)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0519428B1 (en) * 1991-06-21 2000-09-20 Takeda Chemical Industries, Ltd. Cyclodextrin compositions with fumagillol derivates
US5466464A (en) 1991-12-24 1995-11-14 Yamanouchi Pharmaceutical Co., Ltd. Intrabuccally disintegrating preparation and production thereof
GB9318880D0 (en) * 1993-09-11 1993-10-27 Smithkline Beecham Plc Pharmaceutical composition
BR9507768A (pt) * 1994-05-27 1997-09-02 Farmarc Nederland Bv Composição farmacêutica
ATE421318T1 (de) * 1997-02-20 2009-02-15 Massachusetts Inst Technology Darreichungsform, welche rasche dispersionseigenschaften entfaltet, anwendungsverfahren sowie verfahren zur herstellung derselben
BE1011251A3 (fr) * 1997-07-03 1999-06-01 Ucb Sa Compositions pharmaceutiques administrables par voie orale, comprenant une substance active et une cyclodextrine.
TW527195B (en) 1997-10-09 2003-04-11 Ssp Co Ltd Fast-soluble solid pharmaceutical combinations
IL137550A0 (en) * 1998-02-05 2001-07-24 Novartis Ag Epothilone compositions
IT1304190B1 (it) * 1998-12-18 2001-03-08 Euphar Group Srl Clatrati di deidroepiandrosterone e relative composizionifarmaceutiche
US6287603B1 (en) * 1999-09-16 2001-09-11 Nestec S.A. Cyclodextrin flavor delivery systems
CN100455287C (zh) 2002-01-15 2009-01-28 Ucb法奇姆股份有限公司 配方
US7759506B2 (en) 2002-02-25 2010-07-20 Diffusion Pharmaceuticals Llc Bipolar trans carotenoid salts and their uses
PL373780A1 (en) 2002-02-25 2005-09-19 Diffusion Pharmaceuticals Llc Bipolar trans carotenoid salts and their uses
DE10239531A1 (de) * 2002-08-23 2004-03-04 Gulbins, Erich, Prof. Dr. Prophylaxe und Therapie von Infektionserkrankungen
DE10248314A1 (de) * 2002-10-16 2004-04-29 Dr. Suwelack Skin & Health Care Ag Verwendung von Formkörpern zur äußeren Anwendung
FR2876910B1 (fr) * 2004-10-21 2007-04-13 Pierre Fabre Medicament Sa Complexe comprenant la mequitazine, une cyclodextrine et un agent d'interaction
CN104840455A (zh) 2005-02-24 2015-08-19 扩散药品有限公司 反式类胡萝卜素、其合成、制剂和用途
DE102005041860A1 (de) * 2005-09-02 2007-03-08 Schering Ag Nanopartikulärer Einschluss- und Ladungskomplex für pharmazeutische Formulierungen
EP2146948A4 (en) 2007-04-13 2010-08-04 Diffusion Pharmaceuticals Llc USE OF BIPOLAR TRANS-CAROTINOIDES AS PRE-TREATMENT AND TREATMENT OF PERIPHERAL VASCULAR DISEASE
JP2009091309A (ja) * 2007-10-10 2009-04-30 Japan Organo Co Ltd バコパモニエラエキスを含有する組成物およびその製造方法ならびに飲食品
US8206751B2 (en) 2007-10-31 2012-06-26 Diffusion Pharmaceuticals Llc Class of therapeutics that enhance small molecule diffusion
CN102143737A (zh) * 2008-09-05 2011-08-03 麦克内尔-Ppc股份有限公司 制备西替利嗪片剂的方法
JP5787884B2 (ja) 2009-06-22 2015-09-30 ディフュージョン・ファーマシューティカルズ・エルエルシー 拡散増強化合物、及びその単独使用又は血栓溶解剤との併用
WO2011152869A1 (en) 2010-06-02 2011-12-08 Diffusion Pharmaceuticals Llc Oral formulations of bipolar trans carotenoids
EP3210597A1 (en) * 2010-09-13 2017-08-30 Bev-RX, Inc. Aqueous drug delivery system comprising off- flavor masking agent
RU2609198C1 (ru) * 2016-01-25 2017-01-30 Закрытое Акционерное Общество "БИОКОМ" Твердая лекарственная форма имипрамина немедленного высвобождения и способ ее получения
EP3432929A4 (en) 2016-03-24 2019-11-27 Diffusion Pharmaceuticals LLC USE OF BIPOLAR TRANSCAROTINOIDS WITH CHEMOTHERAPY AND RADIOTHERAPY FOR THE TREATMENT OF CANCER

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1450960A (en) * 1972-10-27 1976-09-29 Ono Pharmaceutical Co Stabilization of prostaglandins
AU2882577A (en) * 1976-10-06 1979-03-22 John Wyeth & Brother Limited Pharmaceutical dosage forms
EP0197571A2 (en) * 1985-03-15 1986-10-15 Janssen Pharmaceutica N.V. Novel derivatives of gamma-cyclodextrin

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4165382A (en) * 1977-10-17 1979-08-21 Jose Pozuelo Method of pharmacologically treating schizophrenia with alpha-methyl-para-tyrosine
US4349472A (en) * 1979-04-27 1982-09-14 Schering Corporation (S)-8(1-Adamantanecarbonyloxy)-7-chloro-3-methyl-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine
US4284555A (en) * 1979-04-27 1981-08-18 Schering Corporation 7-Chloro-8(substituted amino carbonyloxy)-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepines
US4477378A (en) * 1980-02-05 1984-10-16 Schering Corp. Esters of substituted 8-hydroxy-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepines
EP0204003A4 (en) * 1984-11-27 1987-06-03 Dainippon Pharmaceutical Co 2-(1-piperazinyl)-4-substituted phenylquinoline derivatives, process for their preparation, and medicinal composition containing same.
GB8613688D0 (en) * 1986-06-05 1986-07-09 Euro Celtique Sa Pharmaceutical composition

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1450960A (en) * 1972-10-27 1976-09-29 Ono Pharmaceutical Co Stabilization of prostaglandins
AU2882577A (en) * 1976-10-06 1979-03-22 John Wyeth & Brother Limited Pharmaceutical dosage forms
EP0197571A2 (en) * 1985-03-15 1986-10-15 Janssen Pharmaceutica N.V. Novel derivatives of gamma-cyclodextrin

Also Published As

Publication number Publication date
ATE83663T1 (de) 1993-01-15
IE63317B1 (en) 1995-04-05
FR2647343B1 (fr) 1994-05-06
DE69000641D1 (de) 1993-02-04
WO1990014089A1 (fr) 1990-11-29
US5244881A (en) 1993-09-14
YU100790A (en) 1992-05-28
ZA903895B (en) 1991-03-27
KR0163423B1 (ko) 1998-12-01
ATE98867T1 (de) 1994-01-15
IL94460A0 (en) 1991-03-10
NZ233784A (en) 1993-04-28
PT94138A (pt) 1991-01-08
AU5582890A (en) 1991-01-10
DE69005359D1 (de) 1994-02-03
ES2062437T3 (es) 1994-12-16
NO180517B (no) 1997-01-27
PL285327A1 (en) 1991-02-11
ZA903978B (en) 1991-03-27
ES2054289T3 (es) 1994-08-01
IE64370B1 (en) 1995-07-26
IL94459A0 (en) 1991-03-10
CA2017360A1 (fr) 1990-11-24
GR3006655T3 (forum.php) 1993-06-30
EP0399902B1 (fr) 1993-12-22
FI103712B1 (fi) 1999-08-31
JPH0356412A (ja) 1991-03-12
DE69000641T2 (de) 1993-06-09
PT94138B (pt) 1996-12-31
NO180517C (no) 1997-05-07
EP0399902A1 (fr) 1990-11-28
FI103712B (fi) 1999-08-31
NZ233766A (en) 1991-08-27
NO902280L (no) 1990-11-26
DE69005359T2 (de) 1994-05-05
DK0399903T3 (da) 1993-02-08
FI902553A0 (fi) 1990-05-23
IE901862L (en) 1990-11-24
AU631888B2 (en) 1992-12-10
DK0399902T3 (da) 1994-02-14
AU5743390A (en) 1990-12-18
NO902280D0 (no) 1990-05-23
IL94459A (en) 1995-01-24
JP2948271B2 (ja) 1999-09-13
PT94139A (pt) 1991-01-08
DD297915A5 (de) 1992-01-30
PT94139B (pt) 1996-12-31
FR2647343A1 (fr) 1990-11-30
EP0399903A1 (fr) 1990-11-28
TW257672B (forum.php) 1995-09-21
CA2017355A1 (fr) 1990-11-24
IE901821L (en) 1990-11-24
EP0399903B1 (fr) 1992-12-23
KR900017570A (ko) 1990-12-19

Similar Documents

Publication Publication Date Title
AU623779B2 (en) New porus pharmaceutical form and its preparation
DK0695171T3 (da) Lyosfærer indeholdende gonadotropin
ES2157993T3 (es) Benzoilguanidinas, su preparacion y su uso en medicamentos.
MY101566A (en) Pharmaceutical compositions.
AU5892399A (en) 1, 2, 4-triazole-3-thione compounds
EP0387821A3 (de) 2-Alkyl-4-arylmethylaminochinoline, ihre Verwendung und daraus hergestellte Arzneimittel
EP0670166A3 (en) Pharmaceutical compositions for oral administration.
BR0212287A (pt) Proteìna de ligação caspase-8, sua preparação e uso
IL95046A0 (en) Substituted 2-imidazolines and pharmaceutical compositions containing them
ITRM920535A1 (it) Composizione farmaceutica per la somministrazione attraverso le mucose.
AR008474A1 (es) Derivado de 9-dihidroeritromicina a 6,9; 11,12-diciclocarbonato, composicion farmaceutica y preparacion bactericida que lo contienen y su uso
ZA966615B (en) Novel perhydroisoindole derivatives, their preparation and the pharmaceutical compositions which contain them.
IT1258818B (it) Composizioni farmaceutiche orali a base di n5-metiltetraidrofolato di calcio
ZA991068B (en) Novel disubstituted naphthyl derivatives, their preparation, pharmaceutical compositions which contain them and their use for the preparation of medicinal products.
MX9200443A (es) Hidrato de 6-ciclohexil-2'-o-metil-adenosina, procedimiento para su preparacion y composicion farmaceutica que los contiene.